Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

From Non-Alcoholic Steatohepatitis (NASH) to Hepatocellular Carcinoma (HCC): Epidemiology, Incidence, Predictions, Risk Factors, and Prevention
Benedetta Maria Motta, Mario Masarone, Pietro Torre, et al.
Cancers (2023) Vol. 15, Iss. 22, pp. 5458-5458
Open Access | Times Cited: 15

Showing 15 citing articles:

Machine Learning-Based Assessment of Survival and Risk Factors in Non-Alcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma for Optimized Patient Management
Miguel Suárez, Sergio Gil-Rojas, Pablo Martínez-Blanco, et al.
Cancers (2024) Vol. 16, Iss. 6, pp. 1114-1114
Open Access | Times Cited: 6
Review of Related Factors for Persistent Risk of Hepatitis B Virus-Associated Hepatocellular Carcinoma
Nevin Varghese, Amry Majeed, Suraj Nyalakonda, et al.
Cancers (2024) Vol. 16, Iss. 4, pp. 777-777
Open Access | Times Cited: 5
Namodenoson at the Crossroad of Metabolic Dysfunction-Associated Steatohepatitis and Hepatocellular Carcinoma
Ohad Etzion, Avital Bareket‐Samish, David Yardeni, et al.
Biomedicines (2024) Vol. 12, Iss. 4, pp. 848-848
Open Access | Times Cited: 5
Inflammatory Response in the Pathogenesis and Treatment of Hepatocellular Carcinoma: A Double-Edged Weapon
Linda Galasso, Lucia Cerrito, Valeria Maccauro, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7191-7191
Open Access | Times Cited: 5
Epidemiology of Hepatocellular Carcinoma in Taiwan
Yu‐Wei Lai, Ching‐Hu Chung
Clinics and Practice (2024) Vol. 14, Iss. 2, pp. 570-578
Open Access | Times Cited: 4
Gut Microbiome Modulation in Hepatocellular Carcinoma: Preventive Role in NAFLD/NASH Progression and Potential Applications in Immunotherapy-Based Strategies
Elisa Monti, Clara Vianello, Ilaria Leoni, et al.
Cells (2025) Vol. 14, Iss. 2, pp. 84-84
Open Access
A novel telomere-associated genes signature for the prediction of prognosis and treatment responsiveness of hepatocellular carcinoma
Kuo Kang, Hui Nie, Weilu Kuang, et al.
Biological Procedures Online (2025) Vol. 27, Iss. 1
Open Access
Role of genetic variants and DNA methylation of lipid metabolism-related genes in metabolic dysfunction-associated steatotic liver disease
Junjie Wang, Xiaohong Chen, Yirong Zhang, et al.
Frontiers in Physiology (2025) Vol. 16
Open Access
Circular RNA in liver cancer research: biogenesis, functions, and roles
Jia‐Yi Wang, Congcong Zhang, Yinghui Zhang, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Role of cholesterol homeostasis in MASH-driven hepatocellular carcinoma: not just a neutral fat
Vicent Ribas
(2024), pp. 203-225
Open Access | Times Cited: 3
Predictive role of neutrophil percentage-to-albumin ratio, neutrophil-to-lymphocyte ratio, and systemic immune-inflammation index for mortality in patients with MASLD
Kaixuan Dong, Ya Zheng, Yuping Wang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Dynamic contrast enhanced ultrasound in differential diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis
Giorgio Esposto, Paolo Santini, Fabrizio Termite, et al.
World Journal of Gastrointestinal Oncology (2024) Vol. 16, Iss. 6, pp. 2804-2815
Open Access | Times Cited: 2
Risk factors of hepatocellular carcinoma associated with nonalcoholic fatty liver disease: Systematic review and meta-analysis
Huimin Yin, Zhanjie Yan, Fangcheng Zhao
Technology and Health Care (2024), pp. 1-12
Closed Access | Times Cited: 2
Global Burden of Pancreatic Cancer Attributable to High Body-Mass Index in 204 Countries and Territories, 1990–2019
Irena Ilić, Milena Ilić
Cancers (2024) Vol. 16, Iss. 4, pp. 719-719
Open Access | Times Cited: 1
Surgical Implications for Nonalcoholic Steatohepatitis-Related Hepatocellular Carcinoma
Centura R. Anbarasu, Sophia Williams‐Perez, E. Ramsay Camp, et al.
Cancers (2024) Vol. 16, Iss. 16, pp. 2773-2773
Open Access
Salidroside may target PPARα to exert preventive and therapeutic activities on NASH
Xueru Chu, Shousheng Liu, Baozhen Qu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Statins decrease the risk of hepatocellular carcinoma in metabolic dysfunction-associated steatotic liver disease: A systematic review and meta-analysis
Zahid Ijaz Tarar, Umer Farooq, Faisal Inayat, et al.
World Journal of Experimental Medicine (2024) Vol. 14, Iss. 4
Closed Access
Page 1

Scroll to top